Viewing Study NCT00947856


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2025-12-30 @ 11:21 PM
Study NCT ID: NCT00947856
Status: COMPLETED
Last Update Posted: 2017-02-02
First Post: 2009-07-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study
Sponsor: Seagen Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SGN35-006
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View